Masters and Doctoral Programs in Physical Therapy, Universidade Cidade de São Paulo, São Paulo, Brazil.
Department of Health Sciences, Faculty of Earth and Life Sciences, VU University Amsterdam, Amsterdam, Netherlands.
Cochrane Database Syst Rev. 2023 Apr 5;4(4):CD009711. doi: 10.1002/14651858.CD009711.pub2.
There is widespread agreement amongst clinicians that people with non-specific low back pain (NSLBP) comprise a heterogeneous group and that their management should be individually tailored. One treatment known by its tailored design is the McKenzie method (e.g. an individualized program of exercises based on clinical clues observed during assessment).
To evaluate the effectiveness of the McKenzie method in people with (sub)acute non-specific low back pain.
We searched CENTRAL, MEDLINE, Embase and two trials registers up to 15 August 2022.
We included randomized controlled trials (RCTs) investigating the effectiveness of the McKenzie method in adults with (sub)acute (less than 12 weeks) NSLBP.
We used standard methodological procedures expected by Cochrane.
This review included five RCTs with a total of 563 participants recruited from primary or tertiary care. Three trials were conducted in the USA, one in Australia, and one in Scotland. Three trials received financial support from non-commercial funders and two did not provide information on funding sources. All trials were at high risk of performance and detection bias. None of the included trials measured adverse events. McKenzie method versus minimal intervention (educational booklet; McKenzie method as a supplement to other intervention - main comparison) There is low-certainty evidence that the McKenzie method may result in a slight reduction in pain in the short term (MD -7.3, 95% CI -12.0 to -2.56; 2 trials, 377 participants) but not in the intermediate term (MD -5.0, 95% CI -14.3 to 4.3; 1 trial, 180 participants). There is low-certainty evidence that the McKenzie method may not reduce disability in the short term (MD -2.5, 95% CI -7.5 to 2.0; 2 trials, 328 participants) nor in the intermediate term (MD -0.9, 95% CI -7.3 to 5.6; 1 trial, 180 participants). McKenzie method versus manual therapy There is low-certainty evidence that the McKenzie method may not reduce pain in the short term (MD -8.7, 95% CI -27.4 to 10.0; 3 trials, 298 participants) and may result in a slight increase in pain in the intermediate term (MD 7.0, 95% CI 0.7 to 13.3; 1 trial, 235 participants). There is low-certainty evidence that the McKenzie method may not reduce disability in the short term (MD -5.0, 95% CI -15.0 to 5.0; 3 trials, 298 participants) nor in the intermediate term (MD 4.3, 95% CI -0.7 to 9.3; 1 trial, 235 participants). McKenzie method versus other interventions (massage and advice) There is very low-certainty evidence that the McKenzie method may not reduce disability in the short term (MD 4.0, 95% CI -15.4 to 23.4; 1 trial, 30 participants) nor in the intermediate term (MD 10.0, 95% CI -8.9 to 28.9; 1 trial, 30 participants).
AUTHORS' CONCLUSIONS: Based on low- to very low-certainty evidence, the treatment effects for pain and disability found in our review were not clinically important. Thus, we can conclude that the McKenzie method is not an effective treatment for (sub)acute NSLBP.
临床医生普遍认为,非特异性下腰痛(NSLBP)患者构成了一个异质群体,其管理应该因人而异。一种以量身定制设计而闻名的治疗方法是麦肯锡疗法(例如,根据评估期间观察到的临床线索制定的个性化锻炼计划)。
评估麦肯锡方法在(亚)急性非特异性下腰痛患者中的疗效。
我们检索了 CENTRAL、MEDLINE、Embase 和两个试验注册处,截至 2022 年 8 月 15 日。
我们纳入了在(亚)急性(少于 12 周)NSLBP 成人中评估麦肯锡方法有效性的随机对照试验(RCT)。
我们使用了 Cochrane 预期的标准方法学程序。
本综述包括 5 项 RCT,共有 563 名参与者来自初级或三级保健机构。三项试验在美国进行,一项在澳大利亚进行,一项在苏格兰进行。三项试验得到了非商业资助者的资助,两项试验未提供资金来源信息。所有试验均存在高偏倚风险。纳入的试验均未测量不良事件。
麦肯锡方法与最小干预(教育手册;麦肯锡方法作为其他干预的补充——主要比较)
有低确定性证据表明,在短期(MD-7.3,95%CI-12.0 至-2.56;2 项试验,377 名参与者),但不是在中期(MD-5.0,95%CI-14.3 至 4.3;1 项试验,180 名参与者),麦肯锡方法可能会导致疼痛略有减轻。有低确定性证据表明,在短期(MD-2.5,95%CI-7.5 至 2.0;2 项试验,328 名参与者)和中期(MD-0.9,95%CI-7.3 至 5.6;1 项试验,180 名参与者),麦肯锡方法可能不会减轻残疾。
麦肯锡方法与手动疗法
有低确定性证据表明,在短期(MD-8.7,95%CI-27.4 至 10.0;3 项试验,298 名参与者),麦肯锡方法可能不会减轻疼痛,并且在中期(MD7.0,95%CI0.7 至 13.3;1 项试验,235 名参与者),可能会导致疼痛略有增加。有低确定性证据表明,在短期(MD-5.0,95%CI-15.0 至 5.0;3 项试验,298 名参与者)和中期(MD4.3,95%CI-0.7 至 9.3;1 项试验,235 名参与者),麦肯锡方法可能不会减轻残疾。
麦肯锡方法与其他干预措施(按摩和建议)
有非常低确定性证据表明,在短期(MD-4.0,95%CI-15.4 至 23.4;1 项试验,30 名参与者)和中期(MD-10.0,95%CI-8.9 至 28.9;1 项试验,30 名参与者),麦肯锡方法可能不会减轻残疾。
基于低至非常低确定性证据,我们的综述中发现的疼痛和残疾治疗效果没有临床意义。因此,我们可以得出结论,麦肯锡方法对(亚)急性非特异性下腰痛没有疗效。